Only three American riders are confirmed for the Tour de France Femmes 2026, with Lily Williams, Heidi Franz and Natalie Quinn representing the United States across the nine stages from Lausanne to Nice.
It is a much smaller US presence than might have been expected when looking at the depth of American riders in the women’s peloton. Olympic road champion Kristen Faulkner, former world time trial champion Chloé Dygert, Megan Jastrab and Ruth Edwards are all absent, but for very different reasons ranging from pregnancy and a disrupted return from injury to teams prioritising different riders and objectives.
That leaves Williams as the strongest established American stage threat, while Franz and Quinn are more likely to build their Tour around breakaways and opportunistic racing. None starts among the main yellow jersey contenders, but the Tour de France Femmes 2026 route provides several days where being outside the GC battle could become an advantage.
Lily Williams is the biggest American stage threat
Lily Williams is the highest-profile American rider on the 2026 start list and the most obvious candidate to produce a US stage result.
Williams was part of the American team pursuit quartet that won Olympic gold in Paris in 2024, but her road career has developed alongside that track success. She is particularly useful on days that sit between a conventional sprint and a full mountain stage, where repeated climbing removes some of the pure sprinters but still leaves a group large enough for her finishing speed to matter.
That gives Human Powered Health several ways to use her. The team do not arrive with a major yellow jersey contender and operate with a relatively flexible leadership structure, something reflected in their Human Powered Health 2026 team guide.
Williams can therefore look for her own result rather than spending the entire Tour protecting somebody else’s GC position.
Harder stages give Williams her best chance
Williams does not want to arrive in Geneva alongside Lorena Wiebes, Charlotte Kool and the other elite pure sprinters with a full peloton behind them.
She becomes more dangerous when the race has already been made difficult.
The opening stage around Lausanne could offer that scenario, while Stage 3 into Poligny is another day where climbing may create a reduced finish rather than a conventional bunch sprint. Williams can also look towards Stages 5 and 6, where an early breakaway has a much stronger chance of surviving.
Those middle stages are particularly interesting because the GC teams have reasons not to control everything. Once the race approaches Mont Ventoux, preserving mountain support for the yellow jersey battle becomes more important than chasing every non-threatening rider up the road.
A reduced group after a hard day is the race Williams wants.
Heidi Franz can build her Tour around breakaways
Heidi Franz joins St Michel-Preference Home-Auber 93 for the 2026 Tour after moving to the French team this season.
Franz is unlikely to be given the same sort of pre-race stage target as Williams, but her team situation gives her something valuable: freedom.
St Michel are not entering the race with a rider expected to challenge Vollering, Ferrand-Prévot or Reusser for yellow. Their Tour is much more likely to be defined by breakaway presence, stage opportunities and making themselves visible when the biggest teams are unwilling to spend resources controlling the race.
Franz has the experience and endurance to fit that approach.
The opening stages may still be too tightly controlled for a move to survive, but the opportunities should increase after the Stage 4 time trial starts separating the GC.
Stages 5 and 6 could be Franz’s best opportunities
The two hilly stages immediately after Dijon stand out.
Stage 5 through Beaujolais includes repeated climbing and a difficult final part of the race, while Stage 6 to Tournon-sur-Rhône comes immediately before the Tour reaches Mont Ventoux.
That timing can make Stage 6 particularly attractive to the breakaway.
The GC teams will know that the following day could decide the Tour and may be reluctant to use their best climbing domestiques simply to bring back riders who are already well down overall.
Franz does not need to match the strongest climbers in the race if her group starts the final hour with several minutes in hand.
She needs to be in the move when it matters.
Natalie Quinn gets the biggest opportunity of her career
Natalie Quinn completes the American trio for Mayenne Monbana My Pie.
The 24-year-old arrives at the Tour from a different position to Williams. This is an opportunity to establish herself at the highest level rather than a race in which a stage victory should already be expected.
Mayenne Monbana My Pie’s presence creates opportunities for that development. They do not bring an obvious Tour GC contender or one of the leading pure sprinters, meaning there is relatively little value in spending the week waiting for the biggest WorldTour teams to decide each stage.
Their route towards a major result is through aggressive racing.
Quinn should be part of that.
The hilly stages are Quinn’s best route into the race
The flatter and mountainous extremes of the Tour are less favourable.
Stage 2 into Geneva should revolve around the leading sprint teams, while Mont Ventoux and the final mountain stage around Nice will place much greater emphasis on the GC favourites.
The middle of the race is more useful.
Stages 5 and 6 give Quinn a realistic chance to make a breakaway, collect climbing points and test herself against riders whose opportunities depend on the same strategy.
She does not need to begin the Tour with a specific stage marked for victory. Getting into the right move can create an opportunity that did not exist at the start of the morning.
That is likely to be the most productive way for Mayenne and Quinn to approach the race.
Photo Credit: GettyWhy isn’t Kristen Faulkner racing the Tour de France Femmes?
Kristen Faulkner is the most obvious missing American name.
The Olympic road race champion would ordinarily be a natural Tour selection because she can time trial, win from breakaways and perform over difficult rolling terrain. She also raced the 2025 Tour, although that campaign ended early after a series of crashes.
Faulkner’s preparation for 2026 came after a difficult previous season. She underwent shoulder surgery in September 2025, bringing that year to an early end and beginning a lengthy recovery. The background to that setback is covered in our report on Kristen Faulkner’s 2025 shoulder surgery.
She returned to competition in 2026 and raced both La Vuelta Femenina and the Giro d’Italia Women, so this is not a straightforward case of Faulkner still being unable to race.
EF Education-Oatly have instead selected Nina Berton, Henrietta Christie, Cédrine Kerbaol, Noemi Rüegg, Alice Towers and Magdeleine Vallieres, building the squad around Kerbaol’s GC possibilities and several different stage-winning options.
The team have not given a simple public explanation that reduces Faulkner’s absence to one factor. Her disrupted route into the season provides important context, but ultimately EF have chosen a different combination of riders for this Tour.
Photo Credit: GettyWhy isn’t Chloé Dygert racing?
Chloé Dygert’s absence is much easier to understand in light of the health and recovery updates she has shared recently.
Dygert has been open about the fact that she still does not feel she ever returned to 100% after the serious crash she suffered in 2020. In a recent Instagram update, she said the lingering effects have continued to limit the level at which she feels able to race, despite returning to competition and winning major titles since the accident.
She has now begun another phase of medical investigation, including specialist laboratory testing focused on chronic inflammation and hormonal disruption, after years of experiencing symptoms that she felt had never been fully explained. Dygert described finally having objective evidence that something has been wrong as a source of relief and validation after a long period of uncertainty.
That medical work is happening alongside another significant physical setback. Dygert has also recently undergone shoulder surgery involving a rotator cuff repair, biceps tenodesis, labrum repair and cyst removal. Her early rehabilitation has restricted her to passive movement for several weeks, with active use of the arm and biceps only due to begin once she receives medical clearance.
That effectively rules out any suggestion that her absence from Canyon SRAM’s Tour squad is simply a tactical selection decision.
Why isn’t Megan Jastrab racing?
Megan Jastrab is a different case again.
Jastrab moved to UAE for 2026 after spending her professional career with Team Picnic PostNL, a transfer covered when UAE confirmed Megan Jastrab’s two-year deal.
Her omission is not easily explained by a lack of results or obvious injury. Jastrab remains an excellent Classics rider with finishing speed, making Stages 1 and 3 especially plausible Tour opportunities.
The problem is the composition of UAE Team L’IMAD’s seven.
They have selected Elisa Longo Borghini, Paula Blasi, Silvia Persico, Maëva Squiban, Dominika Włodarczyk, Brodie Chapman and Mavi García, a squad heavily weighted towards climbing, stage racing and the general classification.
Longo Borghini brings proven Grand Tour leadership, while Blasi has emerged as another major GC card during 2026. García and Persico reinforce the mountain structure, Squiban provides an aggressive stage option, and Chapman and Włodarczyk add further tactical depth.
Jastrab could have given UAE another weapon on the quicker stages, but that is not how the team have chosen to build around their Tour ambitions.
Her absence looks far more like a consequence of GC-focused team selection than an indication that she was unavailable.
Ruth Edwards is absent because of pregnancy
Ruth Edwards has the clearest reason for missing the Tour.
Edwards announced in November 2025 that she was expecting her first child and is therefore away from racing during the 2026 Tour de France Femmes.
That absence comes after one of her strongest performances at last year’s race.
Edwards finished third on Stage 7 into Chambéry after spending the day in the breakaway, securing Human Powered Health’s first Tour de France Femmes stage podium. Her ride is covered in our feature on Ruth Edwards’ 2025 Tour stage podium.
Her pregnancy announcement followed a few months later, and Edwards confirmed the news during the off-season.
Unlike Dygert, Jastrab or Faulkner, there is no selection uncertainty here.
Edwards is not part of the Tour because she is currently away from competition during her pregnancy.
Four major absences for four different reasons
Putting Dygert, Faulkner, Jastrab and Edwards together makes the American contingent look unusually depleted, but they are not four versions of the same story.
Edwards is absent during pregnancy.
Faulkner returned from the shoulder surgery that ended her 2025 season but has not been selected by EF after a disrupted route into 2026.
Jastrab has missed out as UAE load their team heavily towards GC and climbing.
Dygert is not in Canyon SRAM’s selected seven, with the squad already containing two GC leaders and Bäckstedt as an elite time trial option.
That distinction is important because it explains why the United States can have significant depth in the women’s peloton and still arrive at the Tour with only three riders.
Five Americans started the 2025 edition, including Dygert, Faulkner, Edwards, Williams and Jastrab, as covered in our American riders at the 2025 Tour de France Femmes guide.
Only Williams returns in 2026.
There is no American yellow jersey challenge
Williams, Franz and Quinn start with very different objectives from the riders expected to contest the general classification.
None is likely to challenge Vollering, Ferrand-Prévot, Reusser, Longo Borghini or the other leading GC riders across nine stages.
That can become useful rather than limiting.
For a rider hunting stages, losing time early can create tactical freedom. Someone already 10 or 15 minutes behind the yellow jersey poses no meaningful threat to the GC teams, so sending her up the road becomes much easier.
That is the scenario the American riders can exploit.
Their Tour is more likely to be defined by one successful breakaway than by an overall placing.
Which stages best suit the American riders?
Stage 1, Lausanne to Lausanne: Williams is the most interesting US option if the climbing produces a reduced finish.
Stage 2, Aigle to Geneva: The clearest conventional sprint day of the opening stages. None of the American trio starts among the leading favourites.
Stage 3, Geneva to Poligny: Williams becomes more relevant if the Jura terrain reduces the field. Franz can also begin looking towards breakaway opportunities.
Stage 4, Gevrey-Chambertin to Dijon: None of the three US starters is among the headline favourites for the time trial, making the absence of Dygert especially conspicuous.
Stage 5, Mâcon to Belleville-en-Beaujolais: One of the strongest opportunities for all three Americans to join an early move.
Stage 6, Montbrison to Tournon-sur-Rhône: Potentially the best collective chance for the US riders. The GC teams have Mont Ventoux the following day and may be more willing to let a breakaway contest the stage.
Stage 7, Mont Ventoux: The yellow jersey contenders should dominate the race. Support duties and reaching the finish safely are more realistic priorities.
Stage 8, Sisteron to Nice: Williams could become interesting again depending on how much fatigue Ventoux has created and whether the race develops into a conventional sprint.
Stage 9, Nice to Nice: A short mountain finale expected to revolve primarily around the GC battle.
For the wider tactical picture on Stages 5 and 6, our Tour de France Femmes 2026 breakaway specialists guide covers the riders and stages most likely to reward an early move.
-
Photo Credit: Getty
American riders at the Tour de France Femmes 2026
The three confirmed US starters are:
- Lily Williams, Human Powered Health
- Heidi Franz, St Michel-Preference Home-Auber 93
- Natalie Quinn, Mayenne Monbana My Pie
It is a small group, and the absence of several of America’s most decorated riders changes expectations considerably.
There is no Dygert targeting Dijon.
There is no Faulkner as a powerful stage hunter.
There is no Jastrab for the faster selective finishes.
There is no Edwards returning to the breakaway terrain where she reached the Tour podium last year.
That leaves the American challenge built much more around opportunism.
Lily Williams offers the clearest US route to victory
If the United States takes a stage win at the 2026 Tour de France Femmes, Williams is the most obvious place to look.
There is no single stage designed around her strengths in the way Dijon suits the elite time triallists or Geneva favours the pure sprinters. Instead, there are several stages capable of becoming the right race.
Lausanne can become selective. Poligny can produce a reduced group. Stages 5 and 6 can reward a breakaway.
Williams only needs one of those situations to develop in her favour.
Franz and Quinn require a similar degree of tactical freedom, but both can benefit from being riders the GC teams have little incentive to control.
The American contingent is smaller than expected in 2026 and lacks many of the country’s biggest names. That does not leave it without opportunities.
On this Tour, being outside the yellow jersey battle could be exactly what gives the three Americans their best chance to matter.
